Business Description
![Aspira Womens Health Inc Aspira Womens Health Inc logo](https://static.gurufocus.com/logos/0C000007D4.png?14)
Aspira Womens Health Inc
NAICS : 334516
SIC : 3841
ISIN : US92407M2061
Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.27 | |||||
Equity-to-Asset | -0.19 | |||||
Debt-to-Equity | -1.97 | |||||
Debt-to-EBITDA | -0.16 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -106.61 | |||||
Beneish M-Score | -4.17 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 12.7 | |||||
3-Year EBITDA Growth Rate | 8.5 | |||||
3-Year EPS without NRI Growth Rate | 9.7 | |||||
3-Year FCF Growth Rate | 8.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 38.68 | |||||
Future 3-5Y Total Revenue Growth Rate | 65.65 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 12.76 | |||||
9-Day RSI | 15.86 | |||||
14-Day RSI | 18.07 | |||||
6-1 Month Momentum % | -54.81 | |||||
12-1 Month Momentum % | -54.81 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.16 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.64 | |||||
Days Inventory | 26.39 | |||||
Days Sales Outstanding | 63.1 | |||||
Days Payable | 122.78 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.1 | |||||
Shareholder Yield % | 6.49 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.84 | |||||
Operating Margin % | -192.21 | |||||
Net Margin % | -163.95 | |||||
FCF Margin % | -162.94 | |||||
ROA % | -178.45 | |||||
ROIC % | -929.94 | |||||
ROC (Joel Greenblatt) % | -2513.38 | |||||
ROCE % | -598.2 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 1.22 | |||||
EV-to-EBIT | -0.76 | |||||
EV-to-EBITDA | -0.76 | |||||
EV-to-Revenue | 1.46 | |||||
EV-to-Forward-Revenue | 1.19 | |||||
EV-to-FCF | -0.89 | |||||
Price-to-Median-PS-Value | 0.05 | |||||
Earnings Yield (Greenblatt) % | -131.58 | |||||
FCF Yield % | -106.05 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aspira Womens Health Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 8.31 | ||
EPS (TTM) (€) | -1.342 | ||
Beta | 1.36 | ||
Volatility % | 52.55 | ||
14-Day RSI | 18.07 | ||
14-Day ATR (€) | 0.103802 | ||
20-Day SMA (€) | 1.3715 | ||
12-1 Month Momentum % | -54.81 | ||
52-Week Range (€) | 0.77 - 4.8 | ||
Shares Outstanding (Mil) | 12.45 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aspira Womens Health Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aspira Womens Health Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Aspira Womens Health Inc Frequently Asked Questions
What is Aspira Womens Health Inc(FRA:CUL)'s stock price today?
The current price of FRA:CUL is €0.77. The 52 week high of FRA:CUL is €4.80 and 52 week low is €0.77.
When is next earnings date of Aspira Womens Health Inc(FRA:CUL)?
The next earnings date of Aspira Womens Health Inc(FRA:CUL) is 2024-08-14 Est..
Does Aspira Womens Health Inc(FRA:CUL) pay dividends? If so, how much?
Aspira Womens Health Inc(FRA:CUL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |